At close: October 16 at 11:18:05 AM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-29,191.0000
-29,550.0000
-25,899.0000
-24,888.0000
13,835.0000
Investing Cash Flow
-864.0000
14,484.0000
-17,860.0000
565.0000
-154.0000
Financing Cash Flow
35,253.0000
21,233.0000
2,765.0000
58,809.0000
-1,892.0000
End Cash Position
15,508.0000
14,875.0000
8,708.0000
49,702.0000
15,216.0000
Interest Paid Supplemental Data
2,595.0000
2,529.0000
1,823.0000
1,340.0000
975.0000
Capital Expenditure
--
-97.0000
-192.0000
-42.0000
-154.0000
Issuance of Capital Stock
35,752.0000
21,177.0000
2,799.0000
--
--
Issuance of Debt
--
--
--
19,835.0000
--
Repayment of Debt
--
--
--
-13,940.0000
-2,000.0000
Free Cash Flow
-29,275.0000
-29,647.0000
-26,091.0000
-24,930.0000
13,681.0000
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
KLTOW Klotho Neurosciences, Inc.
0.0501
+8.44%
APLMW Apollomics, Inc.
0.0093
0.00%
KMSTF Kadimastem Ltd
0.6404
0.00%
TVGNW Tevogen Bio Holdings Inc.
0.0600
+11.11%
CMRA Comera Life Sciences Holdings, Inc.
0.0002
0.00%
NLSPW NLS Pharmaceutics AG
0.0120
-7.69%
APLIF Appili Therapeutics Inc.
0.0247
-1.20%
CDIOW Cardio Diagnostics Holdings, Inc.
0.0840
+5.00%
GRTSQ Gritstone bio, Inc.
0.0140
+12.00%
QLGN Qualigen Therapeutics, Inc.
4.2014
-1.14%